| Mechanisms of immune evasion in leishmaniasis G Gupta, S Oghumu, AR Satoskar Advances in applied microbiology 82, 155-184, 2013 | 303 | 2013 |
| Mechanisms of cellular invasion by intracellular parasites DM Walker, S Oghumu, G Gupta, BS McGwire, ME Drew, AR Satoskar Cellular and molecular life sciences 71, 1245-1263, 2014 | 204 | 2014 |
| Electrospray encapsulation of toll-like receptor agonist resiquimod in polymer microparticles for the treatment of visceral leishmaniasis AD Duong, S Sharma, KJ Peine, G Gupta, AR Satoskar, EM Bachelder, ... Molecular pharmaceutics 10 (3), 1045-1055, 2013 | 97 | 2013 |
| Quassin alters the immunological patterns of murine macrophages through generation of nitric oxide to exert antileishmanial activity S Bhattacharjee, G Gupta, P Bhattacharya, A Mukherjee, SB Mujumdar, ... Journal of Antimicrobial Chemotherapy 63 (2), 317-324, 2009 | 71 | 2009 |
| Field validation of SYBR green-and TaqMan-based real-time PCR using biopsy and swab samples to diagnose American tegumentary leishmaniasis in an area where Leishmania (Viannia … CM Gomes, MV Cesetti, NA de Paula, S Vernal, G Gupta, RNR Sampaio, ... Journal of clinical microbiology 55 (2), 526-534, 2017 | 65 | 2017 |
| CXC chemokine–mediated protection against visceral leishmaniasis: Involvement of the proinflammatory response G Gupta, S Bhattacharjee, S Bhattacharyya, P Bhattacharya, A Adhikari, ... The Journal of infectious diseases 200 (8), 1300-1310, 2009 | 65 | 2009 |
| Liposomal resiquimod for the treatment of Leishmania donovani infection KJ Peine, G Gupta, DJ Brackman, TL Papenfuss, KM Ainslie, AR Satoskar, ... Journal of Antimicrobial Chemotherapy 69 (1), 168-175, 2014 | 57 | 2014 |
| Miltefosine triggers a strong proinflammatory cytokine response during visceral leishmaniasis: role of TLR4 and TLR9 AK Mukherjee, G Gupta, A Adhikari, S Majumder, SK Mahapatra, ... International immunopharmacology 12 (4), 565-572, 2012 | 56 | 2012 |
| TLR signaling-mediated differential histone modification at IL-10 and IL-12 promoter region leads to functional impairments in tumor-associated macrophages S Banerjee, K Halder, A Bose, P Bhattacharya, G Gupta, S Karmahapatra, ... Carcinogenesis 32 (12), 1789-1797, 2011 | 50 | 2011 |
| Leishmania donovani Infection Induces Anemia in Hamsters by Differentially Altering Erythropoiesis in Bone Marrow and Spleen WP Lafuse, R Story, J Mahylis, G Gupta, S Varikuti, H Steinkamp, ... PLoS One 8 (3), e59509, 2013 | 47 | 2013 |
| Arabinosylated Lipoarabinomannan—mediated protection in visceral Leishmaniasis through up-regulation of toll-like receptor 2 signaling: an immunoprophylactic approach P Bhattacharya, S Bhattacharjee, G Gupta, S Majumder, A Adhikari, ... The journal of infectious diseases 202 (1), 145-155, 2010 | 46 | 2010 |
| Treatment with IP-10 induces host-protective immune response by regulating the T regulatory cell functioning in Leishmania donovani-infected mice G Gupta, S Majumdar, A Adhikari, P Bhattacharya, AK Mukherjee, ... Medical microbiology and immunology 200, 241-253, 2011 | 45 | 2011 |
| Leishmania-Induced Biphasic Ceramide Generation in Macrophages Is Crucial for Uptake and Survival of the Parasite S Majumder, R Dey, S Bhattacharjee, A Rub, G Gupta, ... The Journal of infectious diseases 205 (10), 1607-1616, 2012 | 44 | 2012 |
| Role of hepatic stellate cell (HSC)-derived cytokines in hepatic inflammation and immunity G Gupta, F Khadem, JE Uzonna Cytokines, 2018 | 41 | 2018 |
| Antileishmanial and Cytotoxic Activity of Some Highly Oxidized Abietane Diterpenoids from the Bald Cypress, Taxodium distichum CB Naman, AD Gromovsky, CM Vela, JN Fletcher, G Gupta, S Varikuti, ... Journal of natural products 79 (3), 598-606, 2016 | 38 | 2016 |
| Arabinosylated Lipoarabinomannan Skews Th2 Phenotype towards Th1 during Leishmania Infection by Chromatin Modification: Involvement of MAPK Signaling P Bhattacharya, G Gupta, S Majumder, A Adhikari, S Banerjee, K Halder, ... PloS one 6 (9), e24141, 2011 | 32 | 2011 |
| Osteoarthritis: prognosis and emerging therapeutic approach for disease management A Kumar, P Palit, S Thomas, G Gupta, P Ghosh, RP Goswami, ... Drug Development Research 82 (1), 49-58, 2021 | 28 | 2021 |
| Mycobacterium indicus pranii (Mw)-mediated protection against visceral leishmaniasis: involvement of TLR4 signalling A Adhikari, S Majumder, S Banerjee, G Gupta, P Bhattacharya, ... Journal of antimicrobial chemotherapy 67 (12), 2892-2902, 2012 | 27 | 2012 |
| Mycobacterium indicus pranii (Mw) re-establishes host protective immune response in Leishmania donovani infected macrophages: critical role of IL-12 A Adhikari, G Gupta, S Majumder, S Banerjee, S Bhattacharjee, ... PLoS One 7 (7), e40265, 2012 | 25 | 2012 |
| Northalrugosidine Is a Bisbenzyltetrahydroisoquinoline Alkaloid from Thalictrum alpinum with in Vivo Antileishmanial Activity CB Naman, G Gupta, S Varikuti, H Chai, RW Doskotch, AR Satoskar, ... Journal of natural products 78 (3), 552-556, 2015 | 24 | 2015 |
